The next stage in ADC BIO’s development. Constructing a world-leading ADC facility to support customer needs by expanding into clinical and commercial drug manufacturing. $11million worth of investment well spent.
BIO-CONJUGATION SERVICES > MANUFACTURING
Bringing our vision to life.
A NEW $11M BIO-CONJUGATION FACILITY.
CONSTRUCTION PHASE – COMPLETES SEPTEMBER 2018.
- Purpose built GMP facilities in partnership with engineering specialists WHP.
- Accompanying warehouse, QC and R&D laboratories.
- Occupying ca 60% of 6500m2 space.
- Supporting clinical ADC commercial production.
- Utilising a broad range of technologies – including Lock-Release.